Table 2.
Comparison of the indications and the histopathological results
| Age (Years) | Proliferative– secretory Endometrium | Simple Hyperplasia without atypia | Complex hyperplasia without atypia | Simple Hyperplasia with atypia | Complex hyperplasia with atypia | Endometrial polyp | Endometritis | Endometrial adenocarcinoma | Atrophic endometrium | Insufficient material | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Menometrorrhagia/menorrhagia (3,001) (%) | 44.09+6.25 | 2,021 (67.35) | 227 (7.57) | 33 (1.09) | 14 (0.46) | 27 (0.89) | 247 (8.24) | 141 (4.70) | 27 (0.89) | 32 (1.07) | 232 (7.74) |
| Myoma uteri (456) (%) | 45.37+2.49 | 332 (72.80) | 0 | 0 | 0 | 0 | 57 (12.5) | 31 (6.79) | 0 | 21 (4.61) | 15 (3.29) |
| Post-menopausal bleeding or increased endometrial thickness (411) (%) | 63.31+5.72 | 129 (31.39) | 21 (5.11) | 13 (3.16) | 9 (2.19) | 16 (3.90) | 86 (20.92) | 7 (1.70) | 24 (5.84) | 95 (23.11) | 11 (2.68) |
| Cervical polyp (57) (%) | 45.25+2.40 | 3 (5.26) | 7 (12.28) | 0 | 0 | 0 | 45 (78.95) | 0 | 0 | 0 | 2 (3.51) |
| Adnexal mass (322) (%) | 54.22+1.19 | 217 (67.40) | 27 (8.39) | 2 (0.62) | 1 (0.31) | 14 (4.35) | 9 (2.79) | 25 (7.76) | 6 (1.86) | 12 (3.73) | 9 (2.79) |
| Total 4,247 (%) | 2,702 (63.62) | 282 (6.65) | 48 (1.13) | 24 (0.56) | 57 (1.34) | 444 (10.45) | 204 (4.80) | 57 (1.34) | 160 (3.77) | 269 (6.33) |